Not Signed In -
Hormone Replacement Therapy |
ERT; Estrogen Replacement Therapy; Hormone Replacement Therapy (HRT); HRT |
This article is about the treatment with sex steroids. For hormone replacement therapy in general, and for other instances in which hormones might be prescribed, see hormone therapy. Hormone replacement therapy (HRT) is a system of medical treatment for perimenopausal and postmenopausal women, based on the assumption that it may prevent discomfort and health problems caused by diminished circulating estrogen hormones. The treatment involves a series of drugs designed to artificially boost ...
Wikipedia - [full article]
Hormone Replacement Therapy Clinical Trials
- Hormone Replacement Therapy and Insulin Action: A Double-Blind, Parallel, Placebo-Controlled Hormone Intervention Study in Postmenopausal Women
ClinicalTrials.gov Identifier: NCT00005769 - Active, not recruiting
Menopause
- Hormone Replacement Therapy and the Risk of Breast Cancer Recurrence in Women With Previous Early Stage Breast Cancer
ClinicalTrials.gov Identifier: NCT00003771 - Active, not recruiting
menopausal symptoms; stage I breast cancer; stage II breast cancer; breast cancer in situ
- Hormone Replacement Therapy (HRT) Website Tool
ClinicalTrials.gov Identifier: NCT00319072 - Completed
Communication; Menopause; Hormone Replacement Therapy
- Reduction of Triglycerides in Women on HRT
ClinicalTrials.gov Identifier: NCT00023543 - Active, not recruiting
Cardiovascular Diseases; Atherosclerosis; Postmenopause; Heart Diseases
- Study of Early Hormone Replacement Therapy on Risk Factors for Sudden Cardiac Death
ClinicalTrials.gov Identifier: NCT00580775 - Enrolling by invitation
Menopausal Women
- Assessment of the Transfer of Using Levonorgestrel Intrauterine System (LNG IUS) as a Contraceptive to Using it as Part of Hormone Replacement Therapy (HRT).
ClinicalTrials.gov Identifier: NCT00185458 - Active, not recruiting
Menopause
- A Long-Term Study to Evaluate the Safety of Asoprisnil and Estrogen Administration to Postmenopausal Women
ClinicalTrials.gov Identifier: NCT00152295 - Completed
Postmenopausal, hormone replacement therapy
- A Study to Evaluate the Safety and Effectiveness of Asoprisnil and Estrogen Administration to Postmenopausal Women
ClinicalTrials.gov Identifier: NCT00152282 - Completed
Postmenopausal, hormone replacement therapy
- Hormone Therapy in Treating Patients With Advanced Prostate Cancer
ClinicalTrials.gov Identifier: NCT00003026 - Active, not recruiting
adenocarcinoma of the prostate
- Beneficial Effects of Oral Premarin Estrogen Replacement Therapy Assessed by Human Genome Array
ClinicalTrials.gov Identifier: NCT00318318 - Active, not recruiting
Healthy; Estrogen Replacement Therapy
- Evaluation of rhGH Replacement Therapy in Patients With Pseudohypoparathyroidism Type Ia (PHP Ia)
ClinicalTrials.gov Identifier: NCT00497484 - Active, not recruiting
Pseudohypoparathyroidism; Growth Hormone Deficiency, Dwarfism
- Development and Evaluation of a Hormone Replacement Therapy Decision-Aid
ClinicalTrials.gov Identifier: NCT00012909 - Completed
Menopause
- Hormone Therapy in Treating Patients With Rising PSA Levels Following Radiation Therapy for Prostate Cancer
ClinicalTrials.gov Identifier: NCT00003653 - Active, not recruiting
adenocarcinoma of the prostate; recurrent prostate cancer
- Chemotherapy, Hormone Therapy, and Radiation Therapy in Treating Patients with Locally Advanced Prostate Cancer
ClinicalTrials.gov Identifier: NCT00016913 - Active, not recruiting
adenocarcinoma of the prostate; stage III prostate cancer
- SU5416 Plus Hormone Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
ClinicalTrials.gov Identifier: NCT00026377 - Active, not recruiting
stage II prostate cancer; stage III prostate cancer; stage IV prostate cancer; adenocarcinoma of the prostate
- Epoetin alfa With or Without Dexamethasone in Treating Fatigue and Anemia in Patients With Hormone-Refractory Prostate Cancer
ClinicalTrials.gov Identifier: NCT00060398 - Active, not recruiting
recurrent prostate cancer; Anemia; Fatigue
- Hormone Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
ClinicalTrials.gov Identifier: NCT00005044 - Active, not recruiting
adenocarcinoma of the prostate; stage II prostate cancer; stage III prostate cancer
- Radiologic Evaluation and Breast Density (READ)
ClinicalTrials.gov Identifier: NCT00117663 - Recruiting
Breast Cancer
- Combination Therapy in Treating Patients With Advanced Prostate Cancer That Have Not Responded to Hormone Therapy
ClinicalTrials.gov Identifier: NCT00004001 - Active, not recruiting
adenocarcinoma of the prostate; stage IV prostate cancer; recurrent prostate cancer
- Chemotherapy and Hormone Therapy in Treating Patients With Prostate Cancer
ClinicalTrials.gov Identifier: NCT00003915 - Active, not recruiting
adenocarcinoma of the prostate; stage I prostate cancer
- Combination Chemotherapy Plus Hormone Therapy in Treating Patients With Metastatic Prostate Cancer
ClinicalTrials.gov Identifier: NCT00028769 - Active, not recruiting
adenocarcinoma of the prostate; stage IV prostate cancer; recurrent prostate cancer
- Hormone Therapy and Docetaxel or Hormone Therapy Alone in Treating Patients With Metastatic Prostate Cancer
ClinicalTrials.gov Identifier: NCT00104715 - Recruiting
adenocarcinoma of the prostate; recurrent prostate cancer; stage IV prostate cancer
- Women's Estrogen/Progestin Lipid Lowering Hormone Atherosclerosis Regression Trial (WELL-HART)
ClinicalTrials.gov Identifier: NCT00000559 - Completed
Cardiovascular Diseases; Coronary Disease; Heart Diseases; Myocardial Ischemia; Postmenopause
- Hormone Therapy in Treating Patients Who Have Stage I or Stage II Prostate Cancer
ClinicalTrials.gov Identifier: NCT00003645 - Active, not recruiting
stage II prostate cancer; stage I prostate cancer
- Hormone Therapy Compared With Combination Chemotherapy in Treating Patients With Prostate Cancer
ClinicalTrials.gov Identifier: NCT00027859 - Active, not recruiting
adenocarcinoma of the prostate; stage III prostate cancer
- Bortezomib With or Without Hormone Therapy in Treating Patients With Relapsed Prostate Cancer
ClinicalTrials.gov Identifier: NCT00103376 - Recruiting
adenocarcinoma of the prostate; recurrent prostate cancer
- Postmenopausal Hormone Therapy in Unstable Angina
ClinicalTrials.gov Identifier: NCT00000601 - Completed
Angina, Unstable; Cardiovascular Diseases; Coronary Disease; Heart Diseases; Postmenopause
- Hormone Therapy Plus Radiation Therapy With or Without Combination Chemotherapy in Treating Patients With Prostate Cancer
ClinicalTrials.gov Identifier: NCT00004054 - Active, not recruiting
stage II prostate cancer; stage III prostate cancer; stage IV prostate cancer
- Hormone Therapy Plus Chemotherapy in Treating Children With Acute Lymphocytic Leukemia
ClinicalTrials.gov Identifier: NCT00003437 - Active, not recruiting
recurrent childhood acute lymphoblastic leukemia; untreated childhood acute lymphoblastic leukemia
- High-Dose Esterified Estrogens in Treating Postmenopausal Women With Metastatic Breast Cancer That Has Failed Previous Hormone Therapy
ClinicalTrials.gov Identifier: NCT00131924 - Active, not recruiting
recurrent breast cancer; stage IV breast cancer
- Hormone Therapy and Radiation Therapy or Hormone Therapy and Radiation Therapy Followed by Docetaxel and Prednisone in Treating Patients With Localized Prostate Cancer
ClinicalTrials.gov Identifier: NCT00288080 - Recruiting
Prostate Cancer
- Hormone Therapy Plus Radiation Therapy in Treating Patients With Prostate Cancer
ClinicalTrials.gov Identifier: NCT00003124 - Active, not recruiting
stage II prostate cancer; stage III prostate cancer; stage I prostate cancer; adenocarcinoma of the prostate
- Testosterone in Treating Patients With Progressive Prostate Cancer That No Longer Responds to Hormone Therapy
ClinicalTrials.gov Identifier: NCT00006044 - Active, not recruiting
stage IV prostate cancer; recurrent prostate cancer
- Hormone Therapy With or Without Surgery or Radiation Therapy in Treating Patients With Prostate Cancer
ClinicalTrials.gov Identifier: NCT00002633 - Active, not recruiting
adenocarcinoma of the prostate; stage II prostate cancer; stage III prostate cancer; stage IV prostate cancer
- Hormone Therapy With or Without Mitoxantrone and Prednisone in Treating Patients Who Have Undergone Radical Prostatectomy for Prostate Cancer
ClinicalTrials.gov Identifier: NCT00004124 - Active, not recruiting
adenocarcinoma of the prostate; stage I prostate cancer; stage II prostate cancer; stage III prostate cancer; stage IV prostate cancer; ...
- Rapid Hormone Cycling With Testosterone and Leuprolide Combined With Docetaxel in Treating Patients With Recurrent or Metastatic Adenocarcinoma (Cancer) of the Prostate
ClinicalTrials.gov Identifier: NCT00070369 - Active, not recruiting
adenocarcinoma of the prostate; recurrent prostate cancer; stage IV prostate cancer
- Hormone Replacement Therapy in Relieving Menopausal Symptoms in Postmenopausal Women With Previous Stage I or Stage II Breast Cancer
ClinicalTrials.gov Identifier: NCT00079248 - Active, not recruiting
Osteoporosis; stage I breast cancer; stage II breast cancer; menopausal symptoms; Hot Flashes
- Calcitriol Plus Dexamethasone in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy
ClinicalTrials.gov Identifier: NCT00010231 - Active, not recruiting
stage III prostate cancer; stage IV prostate cancer; adenocarcinoma of the prostate; recurrent prostate cancer
- Hormone Ablation Therapy, Doxorubicin, and Zoledronate With or Without Strontium 89 in Treating Patients With Androgen-Dependent Prostate Cancer and Bone Metastases
ClinicalTrials.gov Identifier: NCT00081159 - Active, not recruiting
recurrent prostate cancer; stage IV prostate cancer; bone metastases
- Oblimersen, Thalidomide, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma
ClinicalTrials.gov Identifier: NCT00049374 - Active, not recruiting
refractory plasma cell neoplasm
- Combination Hormone Therapy Followed by Radiation Therapy in Treating Patients With Prostate Cancer
ClinicalTrials.gov Identifier: NCT00003734 - Active, not recruiting
stage II prostate cancer; stage III prostate cancer; stage IV prostate cancer; stage I prostate cancer; adenocarcinoma of the prostate
- Tipifarnib and Fulvestrant as Second-Line Therapy in Treating Postmenopausal Women With Hormone Receptor-Positive Inoperable Locally Advanced or Metastatic Breast Cancer With Progressive Disease After Previous First-Line Endocrine Therapy
ClinicalTrials.gov Identifier: NCT00082810 - Active, not recruiting
recurrent breast cancer; stage IIIB breast cancer; stage IIIC breast cancer; stage IV breast cancer
- Efficacy of Gynodian® Depot in Women With Impaired Well-Being
ClinicalTrials.gov Identifier: NCT00463450 - Completed
Hormone Replacement Therapy
- Hormone Therapy With or Without Docetaxel And Estramustine in Treating Patients With Prostate Cancer That is Locally Advanced or At High Risk of Relapse
ClinicalTrials.gov Identifier: NCT00055731 - Recruiting
stage III prostate cancer; stage II prostate cancer
- Hormone Therapy Plus Chemotherapy in Treating Patients With Prostate Cancer
ClinicalTrials.gov Identifier: NCT00030654 - Active, not recruiting
adenocarcinoma of the prostate; stage II prostate cancer; stage III prostate cancer; stage IV prostate cancer; recurrent prostate cancer
- Docetaxel, Radiation Therapy, and Hormone Therapy in Treating Patients With Locally Advanced Prostate Cancer
ClinicalTrials.gov Identifier: NCT00099086 - Recruiting
adenocarcinoma of the prostate; stage II prostate cancer; stage III prostate cancer; stage IV prostate cancer
- Tranexamic Acid Vs. Quixil - Reducing Blood Loss in Joint Replacement
ClinicalTrials.gov Identifier: NCT00378872 - Recruiting
Hemorrhage; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee
- Chemotherapy Plus Hormone Therapy Versus Androgen Suppression in Treating Patients With Metastatic or Unresectable Prostate Cancer
ClinicalTrials.gov Identifier: NCT00002855 - Active, not recruiting
adenocarcinoma of the prostate; stage III prostate cancer; stage IV prostate cancer; recurrent prostate cancer
- Radiation Therapy in Treating Patients With Prostate Cancer
ClinicalTrials.gov Identifier: NCT00003290 - Active, not recruiting
stage II prostate cancer; stage III prostate cancer
- Hormone Therapy in Treating Patients With Prostate Cancer
ClinicalTrials.gov Identifier: NCT00003323 - Active, not recruiting
adenocarcinoma of the prostate; recurrent prostate cancer; Quality of Life; sexual dysfunction and infertility
- Combination Chemotherapy in Treating Women With Stage I Breast Cancer
ClinicalTrials.gov Identifier: NCT00055679 - Active, not recruiting
stage I breast cancer
- Suppression of Ovarian Function Plus Either Tamoxifen or Exemestane Compared With Tamoxifen Alone in Treating Premenopausal Women With Hormone-Responsive Breast Cancer
ClinicalTrials.gov Identifier: NCT00066690 - Recruiting
stage I breast cancer; stage II breast cancer; stage IIIA breast cancer
- PS-341 in Treating Patients With Refractory or Progressive Multiple Myeloma
ClinicalTrials.gov Identifier: NCT00049478 - Active, not recruiting
refractory plasma cell neoplasm
- Hormone Replacement Therapy and Prothrombotic Variants
ClinicalTrials.gov Identifier: NCT00049933 - Active, not recruiting
Cardiovascular Diseases; Heart Diseases; Cerebrovascular Accident; Myocardial Infarction; Hypertension
- Estrogen Replacement Therapy in Treating Women With Early-Stage Endometrial Cancer
ClinicalTrials.gov Identifier: NCT00002976 - Completed
stage I endometrial cancer; stage II endometrial cancer; endometrial adenocarcinoma
- Calcitriol and Dexamethasone in Treating Patients With Prostate Cancer Who Have Undergone Surgery or Radiation Therapy
ClinicalTrials.gov Identifier: NCT00054522 - Active, not recruiting
adenocarcinoma of the prostate; recurrent prostate cancer
- Efficacy of FWGE in Combination With Hormone Therapy for the Treatment of Hormone-Refractory Prostate Cancer Patients
ClinicalTrials.gov Identifier: NCT00411853 - Recruiting
Hormone Refractory Prostate Cancer
- Bio-Behavioral Predictors of the Efficacy of Nicotine Replacement Therapy (NRT)
ClinicalTrials.gov Identifier: NCT00326781 - Active, not recruiting
Smoking
- REPLACE: Implantable Cardiac Pulse Generator Replacement Registry
ClinicalTrials.gov Identifier: NCT00395447 - Recruiting
Device Replacement; Elective Replacement (ERI); Device Advisory; Device Upgrade; Postoperative Complications
- Estrogen Replacement and Atherosclerosis (ERA) in Older Women
ClinicalTrials.gov Identifier: NCT00000549 - Completed
Cardiovascular Diseases; Coronary Arteriosclerosis; Coronary Disease; Heart Diseases; Myocardial Ischemia; Postmenopause
- Combination Chemotherapy in Treating Women With Stage II or Stage IIIA Breast Cancer That Has Spread to the Lymph Nodes
ClinicalTrials.gov Identifier: NCT00004125 - Active, not recruiting
Breast Cancer
- Nicotine Replacement Treatment for Pregnant Smokers
ClinicalTrials.gov Identifier: NCT00064948 - Recruiting
Nicotine Dependence; Pregnancy
- Calcitriol and Gefitinib With or Without Dexamethasone in Treating Patients With Advanced Solid Tumors
ClinicalTrials.gov Identifier: NCT00084708 - Active, not recruiting
unspecified adult solid tumor, protocol specific
- Hormone Therapy in Treating Men With Stage IV Prostate Cancer
ClinicalTrials.gov Identifier: NCT00002651 - Recruiting
adenocarcinoma of the prostate; stage IV prostate cancer; recurrent prostate cancer
- Radiation Therapy With or Without Bicalutamide and Goserelin in Treating Patients With Prostate Cancer
ClinicalTrials.gov Identifier: NCT00067015 - Active, not recruiting
adenocarcinoma of the prostate; stage III prostate cancer; Quality of Life
- Combination Chemotherapy and Filgrastim Followed by Radiation Therapy in Treating Patients With Stage II or Stage IIIA Breast Cancer
ClinicalTrials.gov Identifier: NCT00007904 - Active, not recruiting
stage II breast cancer; stage IIIA breast cancer; Male Breast Cancer
- Androgen Suppression Plus Radiation Therapy in Treating Patients With Prostate Cancer
ClinicalTrials.gov Identifier: NCT00006359 - Active, not recruiting
adenocarcinoma of the prostate; stage I prostate cancer; stage II prostate cancer; stage III prostate cancer
- Letrozole With or Without Tipifarnib in Treating Women With Locally Advanced, Locally Recurrent, or Metastatic Breast Cancer
ClinicalTrials.gov Identifier: NCT00060177 - Active, not recruiting
Breast Cancer
- Vaccine Therapy Plus Interleukin-12 in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
ClinicalTrials.gov Identifier: NCT00015977 - Active, not recruiting
adenocarcinoma of the prostate; stage IV prostate cancer; recurrent prostate cancer
- Radiation Therapy With or Without Optional Tamoxifen in Treating Women With Ductal Carcinoma in Situ
ClinicalTrials.gov Identifier: NCT00003857 - Active, not recruiting
breast cancer in situ; intraductal breast carcinoma
- Letrozole With or Without Zoledronate in Treating Healthy Postmenopausal Women With High Breast Density
ClinicalTrials.gov Identifier: NCT00114270 - Active, not recruiting
Breast Cancer; Osteoporosis
- Vaccine Therapy and GM-CSF in Treating Patients With Prostate Cancer That Progressed After Surgery and/or Radiation Therapy
ClinicalTrials.gov Identifier: NCT00108732 - Active, not recruiting
recurrent prostate cancer; stage I prostate cancer; stage II prostate cancer; stage III prostate cancer
- Lenalidomide and Dexamethasone With or Without Thalidomide in Treating Patients With Multiple Myeloma
ClinicalTrials.gov Identifier: NCT00098475 - Active, not recruiting
stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma
- Radiation Therapy and High-Dose Corticosteroids in Treating Older Patients With Primary CNS Non-Hodgkin's Lymphoma
ClinicalTrials.gov Identifier: NCT00003278 - Active, not recruiting
primary central nervous system lymphoma; intraocular lymphoma
- Hormone Replacement Therapy for Hot Flashes and/or Vaginal Symptoms in Postmenopausal Women Receiving Tamoxifen for Breast Cancer
ClinicalTrials.gov Identifier: NCT00026286 - Active, not recruiting
stage I breast cancer; ductal breast carcinoma; menopausal symptoms; Hot Flashes; stage II breast cancer; breast cancer in situ
- Anastrozole Compared With Tamoxifen After Lumpectomy in Treating Postmenopausal Women With Ductal Carcinoma in Situ
ClinicalTrials.gov Identifier: NCT00053898 - Active, not recruiting
breast cancer in situ; intraductal breast carcinoma
- Combination Chemotherapy With or Without Trastuzumab in Treating Women With Breast Cancer
ClinicalTrials.gov Identifier: NCT00005970 - Active, not recruiting
stage I breast cancer; stage II breast cancer; stage IIIA breast cancer
- Combination Chemotherapy in Treating Women With Resected Breast Cancer
ClinicalTrials.gov Identifier: NCT00033683 - Active, not recruiting
stage I breast cancer; stage II breast cancer
- Doxorubicin and Cyclophosphamide Plus Paclitaxel With or Without Trastuzumab in Treating Women With Node-Positive Breast Cancer That Overexpresses HER2
ClinicalTrials.gov Identifier: NCT00004067 - Active, not recruiting
stage II breast cancer; stage IIIA breast cancer
- Effect of Hormone Replacement Therapy on Lupus Activity
ClinicalTrials.gov Identifier: NCT00392093 - Completed
Systemic Lupus Erythematosus
- Nicotine Replacement Therapy for Smoking Cessation in Schizophrenia
ClinicalTrials.gov Identifier: NCT00320723 - Active, not recruiting
Schizophrenia; Schizoaffective Disorder
- Replacement GH Therapy After Bariatric Surgery in Patients With Very Severe Obesity
ClinicalTrials.gov Identifier: NCT00553852 - Active, not recruiting
Obesity; GHD
- Letrozole in Treating Postmenopausal Women Who Have Received Hormone Therapy for Hormone Receptor-Positive Breast Cancer
ClinicalTrials.gov Identifier: NCT00382070 - Recruiting
Breast Cancer
- Study of Patupilone in Prostate Cancer Patients Who Progress After Hormone Therapy and Docetaxel Chemotherapy
ClinicalTrials.gov Identifier: NCT00407251 - Recruiting
Hormone Refractory Prostate Cancer
- Millimeter Wave Therapy (MWT) for Analgesia After Total Knee Replacement
ClinicalTrials.gov Identifier: NCT00233831 - Active, not recruiting
Pain; Acute Pain
- POETRY: Study of Estrogen Replacement Therapy in Postmenopausal Women With Parkinson’s Disease
ClinicalTrials.gov Identifier: NCT00234676 - Active, not recruiting
Parkinson's Disease
- Alberta Hip and Knee Replacement Project
ClinicalTrials.gov Identifier: NCT00277186 - Active, not recruiting
Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee
- IGF-I/IGFBP-3 Therapy in Children and Adolescents With Growth Hormone Insenitivity Syndrome (GHIS) Such as Laron Syndrome
ClinicalTrials.gov Identifier: NCT00368173 - Active, not recruiting
Growth Hormone Insensitivity Syndrome (GHIS); Laron Syndrome
- Cardiac Hormone Replacement With Brain Natriuretic Peptide (BNP) in Heart Failure
ClinicalTrials.gov Identifier: NCT00252187 - Recruiting
Congestive Heart Failure; Cardiomyopathy
- Study of Subcutaneous Immunoglobulin Human in Patients With PID Requiring IgG Replacement Therapy
ClinicalTrials.gov Identifier: NCT00419341 - Active, not recruiting
Primary Immunodeficiency (PID)
- Combined Hormone Replacement in Menstrually-Related Mood Disorders
ClinicalTrials.gov Identifier: NCT00005011 - Recruiting
Premenstrual Syndrome
- Celecoxib in Treating Postmenopausal Women Who Are Undergoing Surgery for Invasive Breast Cancer
ClinicalTrials.gov Identifier: NCT00070057 - Active, not recruiting
stage I breast cancer; stage II breast cancer; stage IIIA breast cancer; stage IIIB breast cancer; stage IIIC breast cancer
- New Oral Anticoagulant Therapy for the Prevention of Blood Clots Following Hip or Knee Replacement Surgery
ClinicalTrials.gov Identifier: NCT00074828 - Completed
Total Knee Replacement; Total Hip Replacement
- Dexamethasone With or Without Lenalidomide in Treating Patients With Newly Diagnosed Stage I, Stage II, or Stage III Multiple Myeloma
ClinicalTrials.gov Identifier: NCT00064038 - Active, not recruiting
stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma
- Adjuvant Radiation Therapy Compared With Observation After Surgery in Treating Women With Estrogen Receptor Positive or Progesterone Receptor Positive Ductal Carcinoma In Situ of the Breast Who Are Receiving Tamoxifen or Anastrozole
ClinicalTrials.gov Identifier: NCT00077168 - Active, not recruiting
intraductal breast carcinoma; breast cancer in situ
- Gefitinib With or Without Tamoxifen in Treating Patients With Tamoxifen-Resistant Metastatic Breast Cancer
ClinicalTrials.gov Identifier: NCT00080743 - Active, not recruiting
recurrent breast cancer; stage IV breast cancer
- Monoclonal Antibody Therapy Plus Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
ClinicalTrials.gov Identifier: NCT00009750 - Active, not recruiting
stage IV prostate cancer; recurrent prostate cancer
- Anastrozole With or Without Trastuzumab in Treating Postmenopausal Women With Metastatic Breast Cancer
ClinicalTrials.gov Identifier: NCT00022672 - Active, not recruiting
stage IV breast cancer; recurrent breast cancer
- Bleed Free Treatment of Menopausal Symptoms With New Ultra Low Dose Hormonal Combinations
ClinicalTrials.gov Identifier: NCT00184795 - Completed
Hormone Replacement Therapy, Post-Menopausal
- Radiation Therapy After Surgery, Chemotherapy, and/or Hormone Therapy in Treating Women With Stage II Breast Cancer
ClinicalTrials.gov Identifier: NCT00005983 - Active, not recruiting
stage II breast cancer
email this page
print this page
bookmark this page
feedback on this page
